论文部分内容阅读
微量白蛋白尿是糖尿病肾病的早期标志之一。近年许多研究表明,微量白蛋白尿与高血压密切相关,是高血压患者心血管事件的独立危险因素,进行微量白蛋白尿筛查有助于发现早期肾脏损害与心血管高危人群,从而采取早期干预措施。有效降压是治疗微量白蛋白尿的基础,而血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在减少微量白蛋白尿方面可能具有较好效果。
Microalbuminuria is one of the early signs of diabetic nephropathy. In recent years, many studies have shown that microalbuminuria and hypertension are closely related, is an independent risk factor for cardiovascular events in hypertensive patients, microalbuminuria screening can help find early renal damage and cardiovascular risk groups, so as to take early Interventions. Effective antihypertensive treatment is the basis for the treatment of microalbuminuria, and angiotensin converting enzyme inhibitors and angiotensin receptor blockers may have a better effect in reducing microalbuminuria.